Lipoxin A4 as a possible mediator of the beneficial actions of phosphodiesterase-5 enzyme inhibitors

Lignende værker

• Membrane-Mediated Action of Phosphodiesterase 5 Inhibitors
  af: Anna I. Malykhina, et al.
  Udgivet: (2025-04-01)
• Bioactive Lipids as Mediators of the Beneficial Action(s) of Mesenchymal Stem Cells in COVID-19
  af: Das, Undurti N
  Udgivet: (2020)
• Lipoxin A4 (LXA4) as a Potential Drug for Autoimmune Uveitis
  af: Undurti Narasimha Das
  Udgivet: (2025-11-01)
• Angiotensin-converting enzyme inhibitors and angiotensin receptor blocker in coronavirus disease 2019: Safe and possibly beneficial
  af: Gupta, Nitesh, et al.
  Udgivet: (2020)
• COVID-19 and Phosphodiesterase Enzyme Type 5 Inhibitors
  af: Al-Kuraishy, Hayder M., et al.
  Udgivet: (2020)